Gemtuzumab ozogamicin: Time to resurrect?

Farhad Ravandi, Elihu H. Estey, Frederick R. Appelbaum, Francesco Lo-Coco, Charles A. Schiffer, Richard A. Larson, Alan K. Burnett, Hagop M. Kantarjian

Research output: Contribution to journal › Comment/debate › peer-review

93 Scopus citations

Fingerprint

Dive into the research topics of 'Gemtuzumab ozogamicin: Time to resurrect?'. Together they form a unique fingerprint.